Compare HSIC & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HSIC | CRL |
|---|---|---|
| Founded | 1932 | 1947 |
| Country | United States | United States |
| Employees | N/A | 20100 |
| Industry | Medical Specialities | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 8.3B |
| IPO Year | 1996 | 1999 |
| Metric | HSIC | CRL |
|---|---|---|
| Price | $79.57 | $169.90 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 12 |
| Target Price | $76.00 | ★ $199.64 |
| AVG Volume (30 Days) | ★ 1.1M | 1.1M |
| Earning Date | 01-01-0001 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.42 | N/A |
| Revenue | ★ $13,201,995,000.00 | $1,857,601,000.00 |
| Revenue This Year | $5.33 | $2.51 |
| Revenue Next Year | $3.41 | $4.66 |
| P/E Ratio | $32.88 | ★ N/A |
| Revenue Growth | 5.94 | ★ 10.48 |
| 52 Week Low | $60.56 | $91.86 |
| 52 Week High | $82.80 | $228.88 |
| Indicator | HSIC | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 47.52 | 32.93 |
| Support Level | $73.08 | $146.33 |
| Resistance Level | $79.15 | $164.36 |
| Average True Range (ATR) | 2.37 | 10.68 |
| MACD | -0.18 | -3.27 |
| Stochastic Oscillator | 37.35 | 27.56 |
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.